AzTrials
AzTrials

Preterm BirthPhase 4NCT02746900

Cervical Cerclage for Preventing Spontaneous Preterm Birth in Singleton Pregnancies Without Prior Spontaneous Preterm Birth and With Short Transvaginal Ultrasound Cervical Length

A Phase 4 study testing Cervical cerclage in people with Preterm Birth, run by Federico II University at 1 site in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Spontaneous preterm birth (SPTB) remains the number one cause of perinatal mortality in many countries, including the United States. In singleton gestations a short cervical length (CL) on transvaginal ultrasound (TVU) has been shown to be a good predictor of SPTB. Read more about this study

Who is it for?
Ages 18 to 50 years, women only
Conditions the study is for
Preterm Birth
What is being tested?
Cervical cerclage
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
587 participants
Where
1 siteItaly
Study dates
Apr 2016to Apr 2019
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • 18-50 ages
  • Singleton pregnancy
  • Cervical length <=25mm between 18(0) and 23(6) weeks

Who cannot join

  • Multiple pregnancy
  • Prior spontaneous preterm birth or second trimester losses between 16(0) and 36(6) weeks
  • Cerclage in situ
  • Painful regular uterine contraction and/or preterm labor
  • Ruptured membranes
  • Major fetal defects
Show all 10Show fewer
  • Active vaginal bleeding
  • Placenda previa and/or accreta
  • Cervical dilation >1.5 cm and/or visible membranes by pelvic exam
  • Suspicion of chorioamnionitis

Trial locations and contacts

1 site in 1 country.

Italy1 site, 1 recruiting

  • Gabriele Saccone

    Naples, 80129

    Gabriele Saccone, 339468517, gabriele.saccone@libero.it

    Recruiting

Other trials in Italy

About this study

Spontaneous preterm birth (SPTB) remains the number one cause of perinatal mortality in many countries, including the United States. In singleton gestations a short cervical length (CL) on transvaginal ultrasound (TVU) has been shown to be a good predictor of SPTB.

Different strategies have been adopted for prevention of SPTB. Growing interest has focused on pessary for prevention of SPTB. Cervical pessary is relatively non-invasive, easy to use, does not require anesthesia, can be used in an outpatient clinic setting, and it is easily removed when necessary. However, a recent systematic review and meta-analysis of randomized clinical trials showed that in singleton pregnancies with short cervix, prophylactic use of the pessary did not reduce the rate of spontaneous preterm delivery or improve perinatal outcome. The evidence supports the use of vaginal progesterone in singleton pregnancies with short cervix, while cervical cerclage seems to be beneficial only in the subgroup of women with both prior SPTB and TVU CL ≤25mm. Interestingly, only 235 singletons without prior SPTB,7 and 504 singletons gestations with prior SPTB,6 have been included in randomized studies on cerclage for TVU CL ≤25mm. A meta-analysis of four trials showed that cervical cerclage did not prevent SPTB in women with short TVU CL and without prior preterm birth.7 However, even if the statistical significance were not reached, they found a reduction in SPTB <35 weeks by 16% in singletons with short TVU CL and without prior SPTB (20.6% vs 31.2%; relative risk (RR) 0.84, 95% confidence interval (CI) 0.60 to 1.17) and by 24% in singletons without risk factors for SPTB (25.6% vs 33.3%; RR 0.76, 95% CI 0.52 to 1.15).

Therefore, the aim of this study is to evaluate the efficacy of cervical cerclage in prevention of SPTB in singleton pregnancies with short TVU CL in second trimester, without prior SPTB.

Read the detailed description

Investigators aim to conduct a prospective, multicenter, randomized, open-label, clinical trial at Department of Reproductive Science, University of Naples Federico II. All women included in the study will provide a written informed consent to participate in the study before the randomization.

Women with TVU CL ≤25mm who will meet the inclusion criteria will be counselled by an obstetrician regarding the risk of SPTB as per standard of care. The patient will be given ample time to have all questions addressed and consider participation. If the patient agrees to participate in the study, the informed consent form will be signed and a copy will be given to the patient. Women who are eligible and consent to participate in the study will be randomly assigned to one of two groups: cervical cerclage (i.e. intervention group) or standard obstetric management (i.e. control group).

Investigators planned subgroup analyses according to different CL cutoffs (i.e. <=15 and <=10 mm); type of suture; and according to prior history of cervical surgery (i.e. LEEP or cone biopsy).

Conditions
Preterm Birth
Being tested
Cervical cerclage
Medical subject headings
Premature Birth

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cervical cerclageProcedure or surgery

    McDonald cervical cerclage

Study groups in NCT02746900
Study groupRoleWhat they receive
Cervical cerclageExperimentalAfter the woman is placed in the dorsal lithotomy position and the bladder is emptied with a urinary catheter to reduce the chance of bladder injury, surgical preparation with Betadine will be performed. Breisky retractors and Sims retractors will be used to exposure the entire cervix. Sponge ring forceps will be used to optimized visualization of the cervix and provide the necessary countertraction at the suture entry and exit sites. McDonald technique will be performed placing 4-6 bites circumferentially around the cervix. Only one stitch will be used. The suture will be places as high as feasible
Receives: Procedure: Cervical cerclage
No interventionNo interventionBed rest will be not recommended.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Spontaneous preterm birth (SPTB)

    Measured: Less than 35 weeks gestation

Secondary outcomes (10)

  1. Spontaneous preterm birth (SPTB)

    Measured: Less than 37,34,32,28 and 24 weeks gestation

  2. Gestational age at delivery

    mean gestational age at delivery in weeks

    Measured: Delivery (at birth)

  3. Latency

    mean latency in days (from randomization to delivery)

    Measured: Delivery (at birth)

  4. chorioamnionitis

    chorioamnionitis histologically proven

    Measured: Delivery (at birth)

  5. Birth weight

    in grams

    Measured: Delivery (at birth)

  6. Admission to neonatal intensive care unit

    Measured: Delivery (at birth)

  7. respiratory distress syndrome

    Measured: Delivery (at birth)

  8. low birth weight

    birth weight <2500 grams

    Measured: Delivery (at birth)

  9. intraventricular hemorrhage

    grade 3 or 4

    Measured: Between birth and 28 days of age

  10. neonatal mortality

    death of a live-born baby within the first 28 days of life

    Measured: Between birth and 28 days of age

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Apr 2016 (estimated)
  2. Study startApr 2016
  3. Primary completionApr 2018 (estimated)
  4. Study completionApr 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
587 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02746900
Sponsor's protocol ID
100/16
Status last verified
Apr 2016
First submitted
8 Apr 2016
Last updated
21 Apr 2016
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Cervical cerclage in people with Preterm Birth, run by Federico II University at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 21 Apr 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Spontaneous preterm birth (SPTB) (time frame: Less than 35 weeks gestation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02746900.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Apr 2016.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in